Sleep problems are nearly universal in schizophrenia, and the antipsychotics used to treat the illness can themselves disrupt sleep architecture. Melatonin is one of the most commonly used over-the-counter sleep aids worldwide, and it combines reasonably safely with most antipsychotics. But "reasonably safely" is not the same as "no thought required" — and the right dose, timing, and product really matter.
Melatonin combines safely with most antipsychotics at low physiological doses (0.3 to 1 mg), is most useful for circadian-rhythm sleep problems rather than primary insomnia, and can mildly help antipsychotic-induced metabolic side effects according to small trials.
What melatonin is — and what it isn't
Melatonin is a hormone produced naturally by the pineal gland, which signals darkness to the body and helps regulate the circadian rhythm. As a supplement, it works best as a chronobiotic — a drug that shifts the timing of the sleep-wake cycle — rather than as a strong sedative. Doses of 0.3 to 1 mg, taken about an hour before desired sleep onset, are usually sufficient to produce a circadian effect. Higher doses (3 to 10 mg, common in over-the-counter products) often work no better and may produce next-day grogginess.
The NIH National Center for Complementary and Integrative Health page on melatonin outlines the evidence base.
Pharmacological interactions with antipsychotics
Melatonin is metabolised primarily by CYP1A2, with smaller contributions from CYP2C19 and CYP2C9. This means:
- Strong CYP1A2 inhibitors can raise melatonin levels — this includes fluvoxamine and ciprofloxacin
- Smoking induces CYP1A2 and lowers melatonin levels — smokers may need slightly more
- Melatonin itself does not significantly inhibit or induce CYP enzymes, so it generally does not change antipsychotic levels
The net result is that melatonin is one of the few sleep aids that does not pharmacokinetically interfere with antipsychotic medication. There are no major contraindications with clozapine, olanzapine, risperidone, quetiapine, aripiprazole, or other commonly used agents.
Pharmacodynamic considerations
- Additive sedation — particularly with quetiapine, olanzapine, or trazodone in the same regimen, melatonin can mildly add to drowsiness, especially the morning after
- Lower blood pressure — both antipsychotics and high-dose melatonin can mildly drop blood pressure; rarely a clinical issue
- Dreams — some people on antipsychotics report more vivid dreams when melatonin is added; usually harmless
Where melatonin actually helps
Delayed sleep phase
Many people with schizophrenia, particularly younger patients, run on a delayed circadian rhythm — they cannot fall asleep until 2 or 3 a.m. and would naturally sleep until late morning. This is treatable. Low-dose melatonin (0.5 to 1 mg) taken three to four hours before the desired sleep time, combined with morning bright light exposure, can shift the rhythm earlier over one to two weeks.
Sleep onset insomnia
Melatonin has a modest effect on sleep onset latency — typically reducing time to fall asleep by 10 to 20 minutes. This is real but unlikely to fix severe insomnia by itself. CBT-I (cognitive behavioural therapy for insomnia) has stronger evidence — see CBT for insomnia in schizophrenia.
Metabolic side effects
Several small trials have explored melatonin's potential to reduce antipsychotic-related weight gain and metabolic side effects. A meta-analysis suggests modest benefit for olanzapine-treated patients on parameters like waist circumference and glucose. The effect is modest and not a substitute for diet, exercise, or metformin (see metformin for antipsychotic weight gain).
Tardive dyskinesia
A few small studies have suggested melatonin may help reduce tardive dyskinesia symptoms, possibly through antioxidant effects on the basal ganglia. The data are preliminary and not yet practice-changing, but it is an area of active research.
Product quality matters
Melatonin in the US is regulated as a dietary supplement, not a medication. Independent testing has found that actual melatonin content can vary widely — from less than 20% to more than 480% of label claims. Choose products certified by USP, NSF, or ConsumerLab, or use a pharmaceutical-grade preparation if available.
Many over-the-counter products contain 5 mg or 10 mg per dose, which is much higher than what most clinical research suggests is optimal. Lower-dose preparations (0.3 to 1 mg) are sometimes harder to find in the US but readily available in many other countries.
Insomnia is severe, persistent for weeks, or accompanied by other warning signs — racing thoughts, paranoia returning, voices intensifying. Sleep loss is a key relapse predictor in schizophrenia and warrants prompt evaluation.
Practical questions to ask your prescriber or pharmacist
- What dose of melatonin makes sense for me?
- When should I take it, given my desired sleep time?
- Are any of my other medications affecting melatonin metabolism?
- If melatonin alone is not enough, what is the next step — sleep hygiene, CBT-I, or a prescription sleep aid?
- How long should I try melatonin before deciding it is or isn't working?
The bottom line
Melatonin is among the safer sleep aids to combine with antipsychotics. It does not significantly interact with the metabolism of most antipsychotic drugs, and at low physiological doses it is well tolerated. Its strongest use is for delayed sleep phase and circadian rhythm problems rather than as a knockout sleeping pill. For severe persistent insomnia, melatonin is best thought of as one part of a broader sleep plan that may include sleep hygiene, CBT-I, and prescription medications when needed. Always tell your prescriber what you are taking — even an over-the-counter supplement.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.